Semler Scientific Return on Tangible Equity 2013-2025 | SMLR
Current and historical return on tangible equity values for Semler Scientific (SMLR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Semler Scientific Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.03B | $-0.10B | 285.71% |
| 2024-12-31 | $0.04B | $0.02B | 118.84% |
| 2024-09-30 | $0.02B | $0.02B | 32.99% |
| 2024-06-30 | $0.02B | $0.02B | 26.23% |
| 2024-03-31 | $0.02B | $0.08B | 30.77% |
| 2023-12-31 | $0.02B | $0.07B | 31.23% |
| 2023-09-30 | $0.02B | $0.07B | 31.62% |
| 2023-06-30 | $0.02B | $0.07B | 30.77% |
| 2023-03-31 | $0.02B | $0.06B | 29.09% |
| 2022-12-31 | $0.01B | $0.06B | 26.92% |
| 2022-09-30 | $0.01B | $0.05B | 26.26% |
| 2022-06-30 | $0.01B | $0.05B | 27.37% |
| 2022-03-31 | $0.02B | $0.05B | 35.75% |
| 2021-12-31 | $0.02B | $0.05B | 43.64% |
| 2021-09-30 | $0.02B | $0.04B | 56.38% |
| 2021-06-30 | $0.02B | $0.04B | 69.29% |
| 2021-03-31 | $0.02B | $0.04B | 61.54% |
| 2020-12-31 | $0.01B | $0.03B | 65.88% |
| 2020-09-30 | $0.01B | $0.02B | 70.59% |
| 2020-06-30 | $0.02B | $0.02B | 100.00% |
| 2020-03-31 | $0.02B | $0.02B | 138.78% |
| 2019-12-31 | $0.02B | $0.01B | 164.10% |
| 2019-09-30 | $0.01B | $0.01B | 186.67% |
| 2019-06-30 | $0.01B | $0.01B | 155.56% |
| 2019-03-31 | $0.01B | $0.01B | 166.67% |
| 2018-12-31 | $0.00B | $0.00B | 400.00% |
| 2018-09-30 | $0.00B | $0.00B | -400.00% |
| 2018-06-30 | $0.00B | $0.00B | -88.89% |
| 2018-03-31 | $0.00B | $0.00B | 0.00% |
| 2017-12-31 | $0.00B | $0.00B | 57.14% |
| 2017-09-30 | $0.00B | $0.00B | 57.14% |
| 2017-06-30 | $0.00B | $0.00B | 61.54% |
| 2017-03-31 | $0.00B | $0.00B | 66.67% |
| 2016-12-31 | $0.00B | $0.00B | 72.73% |
| 2016-09-30 | $-0.01B | $0.00B | 266.67% |
| 2016-06-30 | $-0.01B | $0.00B | 640.00% |
| 2016-03-31 | $-0.01B | $0.00B | 0.00% |
| 2015-12-31 | $-0.01B | $0.00B | -640.00% |
| 2015-09-30 | $-0.01B | $0.00B | -222.22% |
| 2015-06-30 | $0.00B | $0.00B | -123.08% |
| 2015-03-31 | $0.00B | $0.00B | -94.12% |
| 2014-12-31 | $0.00B | $0.00B | -76.19% |
| 2014-09-30 | $0.00B | $0.01B | -88.89% |
| 2014-06-30 | $0.00B | $0.01B | -123.08% |
| 2014-03-31 | $0.00B | $0.01B | -228.57% |
| 2013-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.597B | $0.056B |
| Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.001B | 81.03 |
| Thermo Fisher Scientific (TMO) | United States | $160.427B | 19.41 |
| Edwards Lifesciences (EW) | United States | $44.687B | 29.30 |
| Alcon (ALC) | Switzerland | $42.893B | 28.99 |
| IDEXX Laboratories (IDXX) | United States | $41.716B | 47.94 |
| DexCom (DXCM) | United States | $32.976B | 50.97 |
| IQVIA Holdings (IQV) | United States | $28.242B | 15.82 |
| Mettler-Toledo (MTD) | United States | $25.057B | 29.80 |
| STERIS (STE) | Ireland | $22.093B | 24.33 |
| Waters (WAT) | United States | $17.669B | 24.93 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.026B | 0.00 |
| Hologic (HOLX) | United States | $14.267B | 15.50 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.911B | 69.94 |
| Masimo (MASI) | United States | $8.586B | 31.67 |
| Globus Medical (GMED) | United States | $7.791B | 18.57 |
| Glaukos (GKOS) | United States | $5.657B | 0.00 |
| Teleflex (TFX) | United States | $5.019B | 8.29 |
| Integer Holdings (ITGR) | United States | $4.000B | 20.96 |
| TransMedics (TMDX) | United States | $3.806B | 82.74 |
| PROCEPT BioRobotics (PRCT) | United States | $3.261B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.320B | 13.81 |
| Nihon Kohden (NHNKY) | Japan | $2.042B | 23.42 |
| Veracyte (VCYT) | United States | $1.897B | 26.61 |
| Elekta AB (EKTAY) | Sweden | $1.876B | 16.86 |
| Alphatec Holdings (ATEC) | United States | $1.554B | 0.00 |
| Artivion (AORT) | United States | $1.317B | 123.40 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.053B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.931B | 4.95 |
| IRadimed (IRMD) | United States | $0.730B | 37.06 |
| SiBone (SIBN) | United States | $0.713B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.571B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.550B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.538B | 8.37 |
| AxoGen (AXGN) | United States | $0.530B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.417B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.413B | 9.61 |
| Delcath Systems (DCTH) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.364B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.355B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| RxSight (RXST) | United States | $0.300B | 0.00 |
| NeuroPace (NPCE) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Neuronetics (STIM) | United States | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.10 |
| CVRx (CVRX) | United States | $0.218B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.207B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.130B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.123B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.092B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 44.40 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.058B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.42 |